Rohan Palekar - Mar 2, 2022 Form 4 Insider Report for Neoleukin Therapeutics, Inc. (NLTX)

Role
Director
Signature
/s/ Sean Smith, as Attorney-in-Fact for Rohan Palekar
Stock symbol
NLTX
Transactions as of
Mar 2, 2022
Transactions value $
$0
Form type
4
Date filed
3/4/2022, 05:12 PM
Previous filing
Feb 22, 2022
Next filing
May 16, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NLTX Stock Option (Right to Buy) Award $0 +50K $0.00 50K Mar 2, 2022 Common Stock 50K $2.72 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests as to 1/3 of the total shares on each of March 2, 2023, March 2, 2024 and March 2, 2025, subject to the Reporting Person's provision of service to the Issuer on each vesting date.